Cullen Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Cullen Capital Management, LLC holds 11 biotech & pharma companies tracked by BioSniper, totaling $1.36B in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$1.36B
| Company | Shares | Value |
|---|---|---|
| NVSNovartis AG | 2,037,962 | $311.3M |
| JNJJOHNSON & JOHNSON | 1,114,929 | $272.5M |
| MRKMerck & Co., Inc. | 2,073,354 | $249.4M |
| PMPhilip Morris International Inc | 1,187,104 | $196.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 472,736 | $127.9M |
| PFEPFIZER INC | 2,693,507 | $75.6M |
| BMYBRISTOL MYERS SQUIBB CO | 1,119,669 | $67.9M |
| NVONovo Nordisk A/S | 792,355 | $29.1M |
| SNYSanofi | 593,301 | $28.6M |
| ZTSZoetis Inc. | 9,409 | $1.1M |
| ABBVAbbVie Inc. | 1,437 | $313K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.